Dr. Usha Kiran Yenigalla, MD

Dr. Yenigalla practices at Shady Grove Adventist Hospital in Rockville, Maryland.

Dr. Yenigalla's NPI, 1457518268, was assigned on May 20, 2008. Dr. Yenigalla holds Maryland license 71323.

Dr. Yenigalla's primary practice is Shady Grove Adventist Hospital, at 9901 Medical Center Dr, Rockville, MD 20850 in Montgomery County. The practice phone is (301) 279-6155.

Dr. Yenigalla's primary practice is Shady Grove Adventist Hospital in Rockville, Maryland. Dr. Yenigalla is also affiliated with Adventist HealthCare Shady Grove Medical Center. The medical group on file is US Acute Care Solutions (USACS). Dmand AI also links Dr. Yenigalla to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yenigalla practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Yenigalla's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Yenigalla is licensed in Maryland.

CMS data shows 1,650 Medicare services from Dr. Yenigalla across 8 procedure codes in 2024, for 410 Medicare patients. Medicare paid $139,504 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 410 Medicare patients who saw Dr. Yenigalla in 2024. The largest group is 75 to 84, with 141 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yenigalla's median patient age at 72, with 50% women.

In 2024, Dr. Yenigalla wrote 441 Medicare Part D claims for 176 patients. 89% of them were for generic drugs. CMS names the drug for 238 of them, across 15 drugs with 11 or more claims each, at $8,910 in total drug cost. In 2023, CMS named 147 claims across 10 drugs.

Dr. Yenigalla accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 20 general payments to Dr. Yenigalla from 9 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $99.